Description
Atheroklefit Pharmacodynamics
Atheroklefit® is a liquid extract of red clover herb obtained by double extraction of the raw material with 40% ethanol.
According to the results of preclinical studies, the liquid extract of red clover herb has a moderate hypolipidemic effect: it reduces the concentration of total cholesterol, low-density lipoprotein (LDL) and increases the concentration of high-density lipoprotein (HDL).
The mechanism of action of the liquid extract of red clover herb is associated with a redistribution of cholesterol from LDL to HDL, in which cholesterol is quickly metabolized and excreted from the body.
Red clover herb liquid extract also helps to reduce the intensity of lipid peroxidation, resulting in a decrease in lipoprotein peroxidation and normalizes the permeability of the vascular wall.
Indications
Hyperlipidemia type IIa according to Frederickson, mild.
Contraindications .
Hypersensitivity to the components of the drug, age under 18 years, craniocerebral trauma, brain disease, liver disease, marked renal dysfunction, alcoholism.
Caution:
Use in patients with renal dysfunction of mild to moderate severity.
People who have chronic diseases, before using the drug be sure to consult with your doctor.
Pregnancy and lactation:
The drug is contraindicated for use in pregnancy and during breast-feeding. If it is necessary to prescribe the drug during lactation, breastfeeding must be discontinued.
Dosage and administration
- Inside: 1 teaspoon of the drug, pre-diluted in 1/3 cup of water, 3 times a day for 30 minutes before a meal. The course of treatment of 3-6 months.
- The repeated course of treatment is possible by a doctor’s recommendation.
- Before prescribing the drug, the patient should be transferred to a hypocholesterolemic diet, which must be observed during the entire period of therapy.
